ArticleInternational journal of molecular sciences2026
Genome-Wide CRISPR Screens Identify ABCG2-Mediated Drug Resistance to the Threonine Tyrosine Kinase (TTK) Inhibitor CFI-402257 in Breast Cancer.
Kelsie L Thu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.